Pony.ai's Q2 2026 earnings show total revenue of 246 million yuan, up 68.8% YoY. Robotaxi revenue reached 81.92 million yuan, surging 691.2% YoY and accounting for one-third of total revenue. Fleet size reached 1,975 vehicles.
Core Financials: Robotaxi Becomes Largest Growth Engine
On August 18, 2026, Pony.ai (NASDAQ: PONY; HKEX: 02026) released its Q2 earnings. Key figures include:
- Total revenue: 246 million yuan, up 68.8% YoY
- Robotaxi revenue: 81.92 million yuan, up 691.2% YoY, up 40.9% QoQ
- Robotaxi revenue share: one-third of total revenue
- Passenger fare revenue: surged 849.3% YoY, highest single-quarter growth on record
- H1 Robotaxi revenue: 140 million yuan, exceeding full-year 2025
CEO Peng Jun stated: "We are confident in exceeding our full-year Robotaxi revenue target."
Operations: Fleet and User Base Growing
As of June 30, 2026, key operational metrics:
| Metric | Data | Change |
|---|---|---|
| Robotaxi Fleet Size | 1,975 units | Target: 3,500+ by year-end |
| App Registered Users | 1.5M+ | Significant growth from 1M in March |
| Global Test Mileage | 100M+ km | — |
| Fully Driverless Mileage | 40M+ km | — |
| Cash Reserves | 9.435B yuan | Sufficient for expansion |
The 7th-generation Robotaxi, based on BAIC, GAC, and Toyota platforms, is fully operational. Service coverage continues to expand:
- Guangzhou: Expanded from Nansha to city center, covering over 3 million sq km more
- Shenzhen: Extended to Bao'an Airport, Shenzhen Bay Port, and Shekou Cruise Terminal
Fleet Partnership Model Accelerates Global Expansion
Pony.ai's "China + Overseas" dual-engine strategy is gaining momentum:
- Domestic Deepening: Expanding fleet size and density in Beijing, Shanghai, Guangzhou, and Shenzhen
- Overseas Expansion: Locked over 4,000 units in overseas deployment plans
- Uber Partnership: Plans to deploy over 2,000 units across five European cities
- Multi-Market Testing: Luxembourg testing with Bolt and Stellantis; Singapore open to public
For more autonomous driving industry news, visit EX1000.COM.
Financial Health: Losses Narrowing
Q2 financial improvements:
- Operating expense growth significantly below revenue growth
- Net loss narrowed 14.9% YoY, 15.3% QoQ
- Gross margin: 17.5%, up from 16.1% in Q2 2025
- Debt-to-asset ratio: only 4.88%, no interest-bearing debt
